1.1
The Social Services Legislation Amendment (Drug Testing Trial) Bill 2018
is the Government's attempt, in the face of universal opposition from health,
mental health and addiction experts and community-based organisations, to bring
back the punitive drug testing of income support recipients.
1.2
This measure would introduce a two year trial of mandatory drug testing
of 5000 new recipients of Newstart Allowance and Youth Allowance (other) in the
three trial sites of Mandurah, Western Australia, Logan, Queensland, and
Canterbury-Bankstown, New South Wales. Anyone testing positive for illicit
drugs on the first test will be placed on income management for 24 months. If a
person tests positive on more than one test in 24 months they will be coerced
into drug treatment.
1.3
This measure was originally incorporated in the Social Services
Legislation Amendment (Welfare Reform) Bill 2017, and this Committee held an
inquiry into that Bill at that time. That inquiry received evidence from
experts across the health, mental health and addiction sectors who unanimously
expressed their strong concerns about the impacts these trials would have on
income support recipients, and called on the Committee to reject this schedule.[1]
1.4
The Government was subsequently forced to remove the drug testing
schedule from that Bill when it was clear that the Senate would not support it.
1.5
The Australian Greens share the disappointment and dismay of the experts
and community organisations at the reemergence of this measure in this Bill.
The Government's continuing pursuit of this flawed policy indicates their total
failure to listen to the advice of those with expertise in this field, and
dogged determination to pursue a punitive, ineffective and damaging policy in
the face of all evidence.
1.6
The trial proposed in this new Bill is identical to that which was
proposed, and rejected, previously, with two additions. Firstly, the three
trial sites of Canterbury-Bankstown, Logan and Mandurah are included in the legislation.
Secondly, there is new sub-clause to be included in the Social Security
(Administration) Act 1999, which stipulates where the Secretary has reason to
believe that income management would pose a serious risk to the relevant person's
mental, physical or emotional wellbeing, they must determine that the person
not be subject to income management. The hearings of the Committee's current
inquiry highlighted a range of further issues including key issues which relate
to the specific sites.
Drug treatment
1.7
The lack of drug treatment options for those battling addiction in
Australia was a key area of concerns for submitters during this inquiry as it
was in the previous inquiry.
1.8
Professor Lisa Maher, Professor and Program Head, Kirby Institute for
Infection and Immunity summed up the problem of lack of services, and the
futility of drug testing in this context:
...while we know that drug treatment is effective and
evidence based there's an undersupply of drug treatment in Australia at the
moment. Demand exceeds supply. In any given year we currently treat about half
of those people who are indicated for and seek drug treatment. The proposed
legislation does not address this treatment shortfall and there's little point
in testing people, and certainly no point in penalising them, if there's no
treatment available to them.[2]
1.9
Professor Alison Ritter of the National Drug and Alcohol Research Centre
(NDARC) reiterated this point:
...we are treating about half the people who are currently
seeking treatment. So treatment investment that would meet existing demand
would need to be doubled. The current national treatment investment is around
$1 billion, so an additional $1 billion nationally would be required to meet
current unmet demand for treatment. That's a national estimate. It doesn't
speak to the three specific sites. But there's no reason to suggest that those
three sites have better treatment service provision than any other sites across
Australia.[3]
1.10
Further to this, Ms Charmaine Crowe, Senior Policy and Advocacy Officer
at the Australian Council of Social Service, outlined that drug testing is
likely to increase demand for the already struggling treatment services, along
with other measures forced through in the Social Services Legislation Amendment
(Welfare Reform) Bill 2017. She said:
Our concern would be that this policy is just going to
aggravate that. We should also remember that the welfare reform bill will
coerce a number of people into treatment as well across Australia. So it's not
just this bill that may well increase demand for services; it's going to exist
with other pieces of legislation too.[4]
1.11
The Australian Greens hold that the lack of funding for drug treatment
services across Australia is well known and of significant concern even without
the drug testing trial proposal. The $10 million that the Government says it is
committing to improve services in the trial areas is unlikely to fill the gaps
in services that currently exist. It means that many of those who wish to seek
assistance for their addiction issues will be unable to access treatment. In
the context of the trial it is both deeply unfair and a farce; people will be
punished for their addiction without having access to help for recovery, and
for those that are coerced into treatment through the trial, there will be no
certainty of access to such a service.
1.12
Mandatory drug treatment for addiction was roundly dismissed as contrary
to all evidence in this inquiry, as it was in the original inquiry. Ms Imogen
Ebsworth, Director of Policy and Research at Anglicare Australia, summed up the
view of experts:
...the proposals here to run a mandatory drug trial of people
who are unemployed, with the idea of catching them out if they happen to have
used an illicit substance or a small list of them, will somehow lead to their
rehabilitation and treatment is exactly the opposite of what experts recommend.
In fact, there is no evidence to support this approach at all.[5]
1.13
The announcement from the Government that they would provide $10 million
for additional treatment services across the three trial sites is insufficient
and to date no clear information is available for how that money will be
targeted.
1.14
In each of the proposed trial sites witnesses also raised concerns about
the impact of the trial on other social services, such as accommodation, mental
health and emergency relief. Existing services cannot meet demand and witnesses
were deeply concerned that the trial would increase demand that could not be
met.
Access to pharmacotherapies for addiction
1.15
As well as the lack of treatment services available, the Committee heard
that there are financial barriers to access to opioid substitution therapy
(OST).
1.16
Professor Maher highlighted the situation in Bankstown:
...It's very hard to get on a public OST program at the moment
and has been for some time because these are services that don't charge a
dispensing fee. If you're on a private program, you're required to pay a daily
dispensing fee for your medication, which can be $7 or $8 a day. For somebody
on a low income or a restricted income, this presents a real challenge.[6]
1.17
In explaining that people on income support could be paying $56 per week
or more for their OST prescription alone, Professor Maher explained one
client's situation:
...this client said to me, 'I'm still jumping fences to pay
for my methadone'—still committing crime because of the dispensing fee to get
their daily dose. It's an unintended consequence of the way that those
structures are funded at the moment and the restrictions on access to free
public treatment.[7]
1.18
The Deputy Mayor of Logan City Council, in a response to a question on
notice from the hearing regarding whether access to methadone was an issue in
the City of Logan, said:
Acting Executive Director, Addiction and Mental Health
Services, Queensland Health Metro South Hospital and Health Service, Ms Linda
Hipper, has provided Council with the following information relating to access
to methadone in the City of Logan:
-
There a small number of private
prescribers that provide access to opioid replacement therapies such as
methadone and buprenorphine in nearby suburbs, all of which are informing that
they are at capacity at present.
-
The majority of clients receiving
welfare assistance who are accessing opioid replacement therapies, such as
methadone, are likely to be accessing the public clinic located in Logan
Central operated by Metro South Addiction and Mental Health Services. This is
because there are no consultation fees involved at the public clinic. Private
prescribers vary between bulk billing and charging a gap consultation fee.
-
All clients receiving opioid
replacement therapies are required to pay a dispensing fee at their community
pharmacy which anecdotally has been reported to be between $4 and $8 per day.
-
Within the public clinic all
clients are triaged. Assessment appointments are available within one to two
weeks for all clients and sooner for clients triaged as priority (usually
pregnant clients, those recently released from prison, or those that are HIV
positive).
-
When assessed as suitable, clients
will be stabilised on their medication within the clinic for the first one to
two weeks. They will then be referred to a nominated community pharmacy to
continue to receive their daily dose.
-
Clients are not routinely dosed
within the clinic beyond the initial stabilisation phase, and even during
stabilisation they will be dosed at community pharmacies at weekends and public
holidays.
As can be seen from the above information, there are a number
of challenges with accessing opioid replacement programs, such as methadone, in
the City of Logan.[8]
1.19
It is unacceptable that this key treatment for addiction is so
unaffordable for many in the Canterbury-Bankstown and Logan trial sites.
Increasing stigma and poverty
1.20
A key issue of concern for many submitters to the inquiry was that not
only will this measure not serve to help anyone currently affected by drug
addiction, it is in fact likely to exacerbate already vulnerable people's
deprivation, stigma, inequality and disadvantage.
1.21
Dr Falzon, Chief Executive Officer at St Vincent de Paul Society
National Council of Australia, made this point in evidence to the Committee:
...this legislation will not lead to the desired outcomes and
will actually divert resources from services and evidence-based approaches that
would be successful. It also has the potential to create greater levels of
harm, including increased stigma, marginalisation and poverty. While reducing
the harmful effects of drug addiction is a legitimate policy objective, the
social security system is neither an appropriate nor effective lever for
achieving such outcomes.
In our submission, we have argued that the measures in this
bill are not reasonable, necessary or proportionate. When Australian experts in
the field conclude almost unanimously that there is no evidence that the drug
testing of income support recipients will be successful in treating and
addressing the causes of drug addiction, it cannot be argued that such a
measure is reasonable.[9]
1.22
Professor Maher further outlined that there is evidence that this
measure would increase stigma and marginalisation:
while there's no evidence that testing of social security
recipients is an effective approach there is some evidence that measures like
these have the potential to increase harm, including the harms of stigma,
marginalisation and poverty. In Australia poverty remains the major issue for
people with alcohol and other drug dependence. Any policy that increases in the
quality reduces health outcomes. This is particularly important in populations
and areas where drug use reflects underlying economic and structural
disadvantage, such as in Bankstown, where Vietnamese Australians make up the
largest group of non-Australian born residents followed by residents born in
Lebanon.[10]
1.23
Once again we see this Government pursuing a policy which the evidence
shows will only add to the marginalisation and disadvantage faced by some of
the most vulnerable members of our community. The Australian Greens condemn
this callous move and implore the Government to listen to the advice of experts
and end this damaging, political move.
Lack of consultation
1.24
In the first inquiry, and in subsequent Senate estimates hearings, the
Committee has found that the Government has neglected to undertake anything
like a sufficient program of consultation on the drug testing trial.
1.25
The Committee received evidence from the local councils relating to the
trial sites who expressed their opposition and concern relating to the trials.
1.26
Councillor Cherie Dalley, Deputy Mayor, Logan City Council outlined that
council's position:
In the light of these outstanding questions, as well as
concerns raised by the medical community, the lack of consultation and the lack
of evidence about the effectiveness of similar measures internationally,
council believe there is further work to be done in order to be able to proceed
with this issue—that is, with the trials.[11]
1.27
Mayor of the City of Canterbury Bankstown, Councillor Khal Asfour told
the Committee he was also not consulted:
I do recall that the minister came to Bankstown to announce
this trial—I'm pretty sure it was in Bankstown. That was the first I'd heard of
it. I could be mistaken, but I'm pretty confident that that did occur. Since
then, as a council, we, as far as I'm aware, have not been spoken to or
consulted with by the government or the department.[12]
1.28
While not taking a position on the virtue of the trials themselves, the
Mayor of the City of Mandurah, Councillor Rhys Williams said:
The initial concerns of this council in the early stages,
when this announcement was made, were the lack of consultation and the lack of
evidence to justify Mandurah as a location. Our submission explores that in
more detail. A lot of the data that was presented is not specific to Mandurah,
and we're left asking: where is the evidence that justifies this policy, and
why is it that we weren't heavily engaged with the consultant? Why weren't we,
as the organisation that probably has the most tentacles into the community and
the greatest awareness of what the community challenges are, not engaged in
that process?[13]
1.29
This lack of consultation extended to all relevant experts. Key
stakeholders were not consulted by the Government prior to the first iteration
of this Bill, and have not been consulted in relation to this new push to
establish the trials. Professor Adrian Reynolds from the Royal
Australasian College of Physicians highlighted their frustrations:
Despite being the peak body representing Australia's
addiction medicine specialists, the RACP and the Australasian Chapter of
Addiction Medicine were not consulted on the measures proposed by the bill
prior to their announcement in the 2017-18 budget. Indeed, the questions I've
heard asked this morning should have been asked before the trial was even put
together and there was a decision to press the 'go' button. We should have
known those things before we even got this far.
If consultation had occurred, the RACP, the chapter and other
health experts would have advised that this drug testing trial is clinically
inappropriate and not designed in a way that will address the issues of
substance dependence. On this basis, our strong advice is that this trial
should not go ahead and that this bill should not progress.[14]
Conclusion
1.30
The proposed trial of drug testing for those on income support has been
roundly condemned by the experts and the evidence shows that quite aside from
assisting anyone living with addiction, it is likely to exacerbate and harm
them.
1.31
The trial sites that have been identified have clearly been chosen
because they have existing income management infrastructure.
1.32
The Government's proposed approach will not differentiate between
recreational drug use and those with an addiction as all people testing
positive will be subject to income management straight away. If the Government
were genuine about addressing addiction, they would not be taking this
approach; instead, they would be listening to experts in addition.
1.33
The Australian Greens join with the range of stakeholders and experts in
adamantly opposing this trial.
1.34
If the trials were to proceed, they would need to be properly evaluated
along the lines of Recommendations 1 and 2 of the Majority Committee Report.
However, the Australian Greens are strongly opposed to drug testing of those
receiving income support.
Recommendation 1
1.35
The Australian Greens recommend that the Bill not be passed.
Senator Rachel Siewert
Navigation: Previous Page | Contents | Next Page